v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (302,308) $ (1,042,092)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation 1,458,607 1,362,934
Amortization of debt issuance costs 35,525 35,526
Unrealized gains on short-term U.S. Treasury Securities (22,746)
Stock based compensation expense related to issuance of restricted stock 3,900 3,900
Increase (decrease) in cash, cash equivalents, and restricted cash from changes in assets and liabilities:    
Other assets 155,960 81,519
Accounts payable and accrued liabilities 326,959 291,074
Due to affiliates (166,655) 152,744
Net cash provided by operating activities 1,489,242 885,605
Cash flows from investing activities:    
Additions to real estate (445,794) (397,189)
Purchase of short-term U.S. Treasury Securities (2,703,754)
Maturity of short-term U.S. Treasury Securities 3,973,739
Net cash (used in) provided by investing activities 824,191 (397,189)
Cash flows from financing activities:    
Scheduled principal payments of mortgage loans (494,135) (471,311)
Net cash used in financing activities (494,135) (471,311)
Net change in cash, cash equivalents, and restricted cash 1,819,298 17,105
Cash, cash equivalents, and restricted cash, beginning of period 4,248,386 11,976,151
Cash, cash equivalents, and restricted cash, end of period 6,067,684 11,993,256
Supplemental disclosures and non-cash transactions:    
Cash paid for interest 1,268,144 1,290,900
Distributions payable to preferred unit holders in our operating partnership $ 385,524 $ 364,653